SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- Cancer

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (1817)3/6/2018 4:26:04 PM
From: DewDiligence_on_SI  Read Replies (1) of 1840
 
The high initial price of Opdivo in Japan was for 2mg/kg dosing in melanoma:

epvantage.com

The FDA label for Opdivo specifies fixed dosing (except during the induction period when used in combination with Yervoy).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext